Effect of Intraoperative Dexmedetomidine Infusion on Postoperative Bowel Movements in Patients Undergoing Laparoscopic Gastrectomy: A Prospective, Randomized, Placebo-Controlled Study

Jin Sun Cho, Hyoung-Il Kim, Ki-Young Lee, Ji Yeong An, Sun Joon Bai, Ju Yeon Cho, Young Chul Yoo, Jin Sun Cho, Hyoung-Il Kim, Ki-Young Lee, Ji Yeong An, Sun Joon Bai, Ju Yeon Cho, Young Chul Yoo

Abstract

Sympathetic hyperactivation is one of the causes of postoperative ileus, which occurs frequently after abdominal surgery and adversely influences the patient's prognosis. We aimed to investigate whether dexmedetomidine (DEX) could attenuate postoperative ileus in patients undergoing laparoscopic gastrectomy. Ninety-two patients were randomized to the control (n = 46) or DEX group (n = 46). DEX was administered at a loading dose of 0.5 μg/kg for 10 minutes, followed by an infusion rate of 0.4 μg/kg/h from insufflation of the pneumoperitoneum to the end of surgery. The primary goal was to compare postoperative bowel movements by evaluating the time to first flatus. The balance of the autonomic nervous system, duration of postoperative hospital stay, and pain scores were assessed. The time to first flatus was shorter in the DEX group compared with the control group (67.2 ± 16.8 hours vs 79.9 ± 15.9 hours, P < 0.001). The low-frequency/high-frequency power ratio during pneumoperitoneum increased in the control group, compared with baseline values and the DEX group. The length of postoperative hospital stay was shorter in the DEX group compared with the control group (5.4 ± 0.7 days vs 5.8 ± 1.1 days, P = 0.04). Patients in the DEX group had lower pain scores and required fewer analgesics at 1 hour postoperatively. DEX facilitated bowel movements and reduced the length of hospital stay in patients undergoing laparoscopic gastrectomy. This may be attributed to the sympatholytic and opioid-sparing effects of DEX.

Conflict of interest statement

The authors have no funding and conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Changes in LF, HF, and the LF/HF ratio. Data are expressed as mean ± standard error of the mean. T1, 10 minutes after induction and intubation; T2, 10 minutes after CO2 insufflation; T3, 1 hour after CO2 insufflation; T4, 2 hours after CO2 insufflation; T5, 10 minutes after CO2 desufflation. P < 0.05 versus baseline; †P < 0.05 versus control group. DEX = dexmedetomidine, HF = high frequency, LF = low frequency.

References

    1. Holte K, Kehlet H. Postoperative ileus: a preventable event. Br J Surg 2000; 87:1480–1493.
    1. Johnson MD, Walsh RM. Current therapies to shorten postoperative ileus. Cleve Clin J Med 2009; 76:641–648.
    1. Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogastroenterol Motil 2004; 16 suppl 2:54–60.
    1. Lee MS, Lee JH, Park do J, et al. Comparison of short- and long-term outcomes of laparoscopic-assisted total gastrectomy and open total gastrectomy in gastric cancer patients. Surg Endosc 2013; 27:2598–2605.
    1. Bickel A, Yahalom M, Roguin N, et al. Power spectral analysis of heart rate variability during positive pressure pneumoperitoneum: the significance of increased cardiac sympathetic expression. Surg Endosc 2002; 16:1341–1344.
    1. Uemura N, Nomura M, Inoue S, et al. Changes in hemodynamics and autonomic nervous activity in patients undergoing laparoscopic cholecystectomy: differences between the pneumoperitoneum and abdominal wall-lifting method. Endoscopy 2002; 34:643–650.
    1. Altaparmakov I, Erckenbrecht JF, Wienbeck M. Modulation of the adrenergic system in the treatment of postoperative bowel atonia. Scand J Gastroenterol 1984; 19:1104–1106.
    1. Steinbrook RA. Epidural anesthesia and gastrointestinal motility. Anesth Analg 1998; 86:837–844.
    1. Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90:699–705.
    1. Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg 2000; 90:834–839.
    1. Rajendra Acharya U, Paul Joseph K, Kannathal N, et al. Heart rate variability: a review. Med Biol Eng Comput 2006; 44:1031–1051.
    1. Kim MG, Kim BS, Kim TH, et al. The effects of laparoscopic assisted total gastrectomy on surgical outcomes in the treatment of gastric cancer. J Korean Surg Soc 2011; 80:245–250.
    1. Okholm C, Goetze JP, Svendsen LB, et al. Inflammatory response in laparoscopic vs. open surgery for gastric cancer. Scand J Gastroenterol 2014; 49:1027–1034.
    1. McLaughlin JG, Scheeres DE, Dean RJ, et al. The adverse hemodynamic effects of laparoscopic cholecystectomy. Surg Endosc 1995; 9:121–124.
    1. Barczynski M, Herman RM. Influence of different pressures of pneumoperitoneum on the autonomic system function during laparoscopy. Folia Med Cracov 2002; 43:51–58.
    1. Rasmussen JP, Dauchot PJ, DePalma RG, et al. Cardiac function and hypercarbia. Arch Surg 1978; 113:1196–1200.
    1. Nilsson F, Jung B. Gastric evacuation and small bowel propulsion after laparotomy. A study with a double isotope technique in rat. Acta Chir Scand 1973; 139:724–730.
    1. Dubois A, Weise VK, Kopin IJ. Postoperative ileus in the rat: physiopathology, etiology and treatment. Ann Surg 1973; 178:781–786.
    1. Luckey A, Livingston E, Tache Y. Mechanisms and treatment of postoperative ileus. Arch Surg 2003; 138:206–214.
    1. Khan ZP, Ferguson CN, Jones RM. alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 1999; 54:146–165.
    1. Figueroa XF, Poblete MI, Boric MP, et al. Clonidine-induced nitric oxide-dependent vasorelaxation mediated by endothelial alpha(2)-adrenoceptor activation. Br J Pharmacol 2001; 134:957–968.
    1. Hogue CW, Jr, Talke P, Stein PK, et al. Autonomic nervous system responses during sedative infusions of dexmedetomidine. Anesthesiology 2002; 97:592–598.
    1. Cho JS, Kim SH, Shin S, et al. Effects of dexmedetomidine on changes in heart rate variability and hemodynamics during tracheal intubation. Am J Ther 2014; [Epub ahead of print].
    1. Neukirchen M, Kienbaum P. Sympathetic nervous system: evaluation and importance for clinical general anesthesia. Anesthesiology 2008; 109:1113–1131.
    1. Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs 2000; 59:263–268.
    1. Bloor BC, Ward DS, Belleville JP, et al. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 1992; 77:1134–1142.
    1. Tan JA, Ho KM. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Med 2010; 36:926–939.
    1. Ferraz AA, Cowles VE, Condon RE, et al. Opioid and nonopioid analgesic drug effects on colon contractions in monkeys. Dig Dis Sci 1995; 40:1417–1419.
    1. De Winter BY, Boeckxstaens GE, De Man JG, et al. Effects of mu- and kappa-opioid receptors on postoperative ileus in rats. Eur J Pharmacol 1997; 339:63–67.
    1. Al-Zaben KR, Qudaisat IY, Al-Ghanem SM, et al. Intraoperative administration of dexmedetomidine reduces the analgesic requirements for children undergoing hypospadias surgery. Eur J Anaesthesiol 2010; 27:247–252.
    1. Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology 1997; 86:331–345.
    1. Kim HC, Lee YH, Jeon YT, et al. The effect of intraoperative dexmedetomidine on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumour resection: a prospective, double-blind, randomised study. Eur J Anesthsiol 2014; 31:1–6.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する